~Purchased by Eagle Pharmaceuticals in June 2022. Reduction in Acacia Employees by 90%.~Recruited to fill a non-performing territory that I successfully moved off the last in rankings in a short period of time. I gained product buy in and consistent growth in a key account that had failed trials (with prior rep) with Barhemsys, a rescue medication for Post Op Nausea and Vomiting. ~Successfully launched 2 new products in the Anesthesia/Critical Care Market during Covid with use in the OR, PACU and ASC. ~Won Formulary approval at a 23 location Interventional Pain Center and ASC with Byfavo, a moderate sedation intraop medication for all procedures 30 minutes of less. ~Trained and educated MD's, CRNA's, AA's and Surgeons on how to use Byfavo and Barhemsys in the OR. ~Specific call points: Plastic Surgeons, Interventional Pain Physicians, Anesthesia, PACU Nurses and General Surgeons.~Moved territory up 2 rankings from last in the company, 25 to 23, in just 4 months. ~Achieved secondary trial consideration by working with my existing relationships in pharmacy at Wellstar Health System to overcome poor trial results with first Barhemsys review prior to my employment.~Won Formulary approval at Cancer Treatment Centers of America Enterprise on my last day of employment with Acacia.

~Maintained top sales in the company for 11 years with Caldolor (IV Ibuprofen). Ranked #1 in the nation for 2013, ranked #1-6 in the Nation for years 2009-2020. ~Promoted multiple injectable products over various call points including Caldolor (IV Ibuprofen), Vibativ (Antibiotic), Ethyol (Organ Protector/Neuropathy prevention in Chemo patients), Totect (used to treat tissue damage caused by leaking of Cancer medications), Vaprisol (Hyponatremia) and Acetadote (Acetaminophen overdose). Marketed to OBGYN, Anesthesia, Surgeons, Pharmacy, ER, Infectious Disease, Critical Care, ICU, Oncology, Home Health Care. Primary Call points were the OR and ASC educating Surgeons and Anesthesiology with Caldolor for intraoperative use for pain control and GYN procedures. ~President’s Award Winner-2013. ~Advisory Board Council Member-2010~ASCEND Promotion to Senior Representative 2013. Second representative ever in company history to receive the promotion and increase in bonus payout. ~Trendsetter Club Winner for 2011 and 2012 for sales growth performance. ~Road Warrior award trip winner 2019 for largest system formulary win in company history. ~2019 Caldolor formulary win, Wellstar Health System. System wide use of Caldolor in all Outpatient Surgery Cases. Helped build their CORE multi-modal protocols for Outpatient Surgery with Anesthesia. ~First representative in the company to successfully transition Caldolor Vial to Caldolor Ready to Use bag in all accounts after new formulation launch in 2020. ~8 out of 11 years, Exceeds Expectations on Performance Reviews. ~Successfully gained ERAS (Multi-modal Opioid Reduction Surgical Protocols) addition in various hospital and surgery center standing orders. ~Gained formulary approval at The Cancer Treatment Center of America in 2015 with ERAS standing orders for all surgical patients. This sales growth led to the National approval of Caldolor throughout the entire enterprise. CTCA is my #2 volume account in my territory.

~Launched Perforomist a Long-Acting Beta Agonist for COPD and other lung conditions. Promoted Epipen for Anaphylactic reactions and Curosurf (Rare Disease) a lung surfactant rescue treatment for RDS in premature infants and Cyanokit (Rare Disease) for Cyanide Poisoning.~Developed key relationships with Hospital, NICU, Long Term Care and Home Health Care accounts, ranking #2 in the nation YTD with newest product launch. ~Finished 2007 #2 in the region, #17 in the nation. ~Through August of 2007 ranked #7 or higher in the nation out of 42 representatives. ~First full month in the field, won the National Sales Award for the most Cyanide Antidote kits placed in Institutions.~Won the Critical Selling Role Play at the National Sales Meeting out of 42 Hospital Representatives. ~Converted 4 hospitals in the Atlanta area to Curosurf (a surfactant for the NICU) in the first 12 months of employment. ~Grew business in 30 hospital accounts with 4 different products across Georgia and Alabama.~Promoted an IV Surfactant, an inhalation Long-Acting Beta Agonist and a Cyanide Rescue Kit to ER doctors, Pulmonologists, Hospitalists, Pharmacists and Neonatologists~Utilized all P&T relationships to obtain formulary approval for all products. ~Conducted successful pull through activity once on formulary to maximize sales growth.~Launched two new products placing them in 15 hospitals since launch in last quarter of 2007.

~Specialty Hospital/CNS representative calling on Psychiatrists and Neurologists with the number one prescribed atypical antipsychotic, Seroquel, in Neurology, Psychiatry and Atlanta area Hosptial Systems.~#1 in district for New Prescription Market Share growth.~Nominated District Trainer-taught numerous Seroquel training classes and conducted multiple teleconferences for Primary Care Representatives.~Piloted “Advanced Training” Class that rolled out nationally to all representatives.~Finished #1 in region in 2004 for retail accounts and #1 for second trimester 2004 in non-retail accounts.~First working trimester after sales training in 2004 finished #2 in region and #5 in nation.~Received highest ratings in financials on performance reviews in 2004 and 2005 with exceeded and distinguished.~Documented success in sales at Grady Memorial Hospital calling on residents and attendings.~Consistently top performer in district, region and nation in 2004 and 2005 with 10.5% market share increase.~Won three regional sales contests for market share increase-STARZ, Top of the Mountain and Zomig Zone.~Nominated by Regional Manager for Seroquel Expert Panel and Field Training Associate.~Had four out of seven bonus payouts at 160% to 200%, making 63% more than target payout.~Successfully took a territory that was last in the region for five years to a #1 territory in six months without a counterpart.~Finished 11th in nation in 2004.~Full email and bonus payout documentation for all achievements.~Received a “Being the Best” award of $500.00 for successfully rolling out an Adherence Program to the region.

~Promoted Lamisil for Onychomycosis, Famvir for herpesvirus infections and Launched Elidel for Atopic Dermatiitis to Atlanta North Dermatologists.~#1 in division and #2 in district for second trimester of 2003.~Only district member to have positive growth trends with second product market share for 2003.~#1 in district for primary product market share and #1 with market share increase.~Second trimester of 2001, earned the#1 representative in the region, #2 in the nation for highest growth in market share of primary product.~Received numerous territory level awards for outstanding sales, demonstrating a solid sales process and role model displays of teamwork including a Frontier Award for highest bonus in district for second trimester 2003.~Successfully moved market share from 9% to 20% in the first six months of a new product launch.~Directly marketed to Neurologists (Exelon), Dermatologists and Internal Medicine doctors with highly complex disease states and medications.~Awarded a Level II Sales Consultant position based on past sales numbers and future promotion potential upon accepting sales position with Novartis.

~Successfully launched Aciphex for GERD, Sporonox for Onychomycosis and Propulsid for Gastric Motility.~Maintained the top 3 of 10 rankings in market share within district.~Awarded 1 of 15 in the southeastern region to attend a “Killer Rep” specialty skill training program.~Completed training program of selling skills and product knowledge to provide and educate facts to the medical industry.~Promoted after six months to a metro Atlanta territory from a rural based territory.~Continued to grow and exceed expectations of market share in a highly saturated managed care territory.~Promoted gastrointestinal and oral anti-fungal medications to metro area Dermatologists and physicians.~Have managed, implemented and successfully hosted district wide speaker programs for large groups of physicians.